Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Agennix AG buy melinda

Agennix AG
Start price
€0.062
16.12.17 / 50%
Target price
€0.20
04.01.18
Performance (%)
12.90%
End price
€0.070
04.01.18
Summary
This prediction ended on 04.01.18 with a price of €0.070. The BUY prediction by melinda finished with a performance of 12.90%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Agennix AG - - - -
iShares Core DAX® 0.881% 5.632% 8.477% 63.917%
iShares Nasdaq 100 2.390% 1.571% 28.412% 91.986%
iShares Nikkei 225® 4.269% 2.521% 50.984% 83.957%
iShares S&P 500 1.171% 2.545% 23.603% 71.357%

Comments by melinda for this prediction

In the thread Agennix AG diskutieren
Prediction Buy
Perf. (%) 12.90%
Target price 0.200
Change
Ends at 04.01.18



Beruf
Logo Agennix AG
Erforscht, entwickelt und vermarktet neue Anti-Krebs - Medikamente

Agennix AG ist ein biopharmazeutisches Unternehmen, engagierte qui in der Entwicklung von Protein-basierten Medikamenten für die Onkologie, Asthma und Wundheilung.

Seine klinischen Entwicklungsprogramme umfassen oral verabreichbares Talactoferrin alfa und RGB-286638.

Das Unternehmen wurde am 5. November 2009 gegründet und ist in Heidelberg, Deutschland hat seinen Hauptsitz.



melinda 
0
Report Share
16.12.17
Prediction Buy
Perf. (%) 12.90%
Target price 0.200
Change
Ends at 04.01.18

(Vom Mitglied beendet)

melinda 
0
Report Share
04.01.18

Stopped prediction by melinda for Agennix AG

buy
Agennix AG

Start price
Target price
Perf. (%)
€0.062
16.12.17
€0.20
04.01.18
12.90%
04.01.18

melinda 
14.08.19 50%